Peter Svennilson's Insider Trades & SAST Disclosures
Peter Svennilson's most recent trade in ORIC Pharmaceuticals Inc was a trade of 16,625 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 16, 2021.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Peter Svennilson.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ORIC Pharmaceuticals Inc | Peter Svennilson | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 16,625 | 16,625 | - | - | Stock Option (right to buy) | |
| RAPT Therapeutics Inc | Peter Svennilson | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 7,500 | 7,500 | - | - | Stock Option (right to buy) | |
| Revolution Medicines Inc | Peter Svennilson | Director | Sale of securities on an exchange or to another person at price $ 42.85 per share. | 26 Apr 2021 | 28,101 | 1,787,660 (3%) | 0% | 42.8 | 1,204,027 | Common Stock |
| Revolution Medicines Inc | Peter Svennilson | Director | Sale of securities on an exchange or to another person at price $ 42.85 per share. | 26 Apr 2021 | 24,883 | 1,582,965 (2%) | 0% | 42.8 | 1,066,147 | Common Stock |
| Revolution Medicines Inc | Peter Svennilson | Director | Sale of securities on an exchange or to another person at price $ 42.65 per share. | 26 Apr 2021 | 12,371 | 1,775,289 (3%) | 0% | 42.7 | 527,659 | Common Stock |
| Revolution Medicines Inc | Peter Svennilson | Director | Sale of securities on an exchange or to another person at price $ 42.65 per share. | 26 Apr 2021 | 10,955 | 1,572,010 (2%) | 0% | 42.7 | 467,263 | Common Stock |
| Revolution Medicines Inc | Peter Svennilson | Director | Sale of securities on an exchange or to another person at price $ 42.51 per share. | 26 Apr 2021 | 53 | 1,775,236 (3%) | 0% | 42.5 | 2,253 | Common Stock |
| Revolution Medicines Inc | Peter Svennilson | Director | Sale of securities on an exchange or to another person at price $ 42.51 per share. | 26 Apr 2021 | 47 | 1,571,963 (2%) | 0% | 42.5 | 1,998 | Common Stock |
| Revolution Medicines Inc | Peter Svennilson | Director | Sale of securities on an exchange or to another person at price $ 44.80 per share. | 08 Apr 2021 | 24,518 | 1,828,862 (3%) | 0% | 44.8 | 1,098,507 | Common Stock |
| Revolution Medicines Inc | Peter Svennilson | Director | Sale of securities on an exchange or to another person at price $ 44.80 per share. | 08 Apr 2021 | 21,710 | 1,619,448 (2%) | 0% | 44.8 | 972,697 | Common Stock |
| Revolution Medicines Inc | Peter Svennilson | Director | Sale of securities on an exchange or to another person at price $ 43.83 per share. | 08 Apr 2021 | 13,101 | 1,815,761 (3%) | 0% | 43.8 | 574,162 | Common Stock |
| Revolution Medicines Inc | Peter Svennilson | Director | Sale of securities on an exchange or to another person at price $ 43.83 per share. | 08 Apr 2021 | 11,600 | 1,607,848 (2%) | 0% | 43.8 | 508,379 | Common Stock |
| Revolution Medicines Inc | Peter Svennilson | Director | Sale of securities on an exchange or to another person at price $ 48.06 per share. | 05 Apr 2021 | 20,949 | 1,868,205 (3%) | 0% | 48.1 | 1,006,847 | Common Stock |
| Revolution Medicines Inc | Peter Svennilson | Director | Sale of securities on an exchange or to another person at price $ 48.06 per share. | 05 Apr 2021 | 18,551 | 1,654,286 (2%) | 0% | 48.1 | 891,594 | Common Stock |
| Revolution Medicines Inc | Peter Svennilson | Director | Sale of securities on an exchange or to another person at price $ 45.60 per share. | 05 Apr 2021 | 14,825 | 1,853,380 (3%) | 0% | 45.6 | 676,087 | Common Stock |
| Revolution Medicines Inc | Peter Svennilson | Director | Sale of securities on an exchange or to another person at price $ 45.60 per share. | 05 Apr 2021 | 13,128 | 1,641,158 (2%) | 0% | 45.6 | 598,696 | Common Stock |
| Revolution Medicines Inc | Peter Svennilson | Director | Sale of securities on an exchange or to another person at price $ 46.65 per share. | 05 Apr 2021 | 9,661 | 1,889,154 (3%) | 0% | 46.7 | 450,732 | Common Stock |
| Revolution Medicines Inc | Peter Svennilson | Director | Sale of securities on an exchange or to another person at price $ 46.65 per share. | 05 Apr 2021 | 8,554 | 1,672,837 (2%) | 0% | 46.7 | 399,085 | Common Stock |
| RAPT Therapeutics Inc | Peter Svennilson | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 2,229 | 2,229 | - | - | Stock Option (right to buy) | |
| Revolution Medicines Inc | Peter Svennilson | Director | Other type of transaction at price $ 0.00 per share. | 09 Dec 2020 | 530,365 | 1,898,815 (3%) | 0% | 0 | Common Stock | |
| Revolution Medicines Inc | Peter Svennilson | Director | Other type of transaction at price $ 0.00 per share. | 09 Dec 2020 | 469,635 | 1,681,391 (2%) | 0% | 0 | Common Stock | |
| Revolution Medicines Inc | Peter Svennilson | Director | Other type of transaction at price $ 0.00 per share. | 09 Dec 2020 | 46,868 | 0 (0%) | 0% | 0 | Common Stock | |
| Revolution Medicines Inc | Peter Svennilson | Director | Other type of transaction at price $ 0.00 per share. | 09 Dec 2020 | 24,857 | 46,868 (0%) | 0% | 0 | Common Stock | |
| Revolution Medicines Inc | Peter Svennilson | Director | Other type of transaction at price $ 0.00 per share. | 09 Dec 2020 | 22,011 | 22,011 (0%) | 0% | 0 | Common Stock | |
| Revolution Medicines Inc | Peter Svennilson | Director | Other type of transaction at price $ 0.00 per share. | 09 Dec 2020 | 13,068 | 20,302 (0%) | 0% | 0 | Common Stock | |
| Revolution Medicines Inc | Peter Svennilson | Director | Other type of transaction at price $ 0.00 per share. | 09 Dec 2020 | 46 | 46 (0%) | 0% | 0 | Common Stock | |
| Revolution Medicines Inc | Peter Svennilson | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 36.40 per share. | 16 Nov 2020 | 1,075,133 | 2,429,180 (4%) | 1% | 36.4 | 39,134,841 | Common Stock |
| Revolution Medicines Inc | Peter Svennilson | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 36.40 per share. | 16 Nov 2020 | 952,023 | 2,151,026 (3%) | 1% | 36.4 | 34,653,637 | Common Stock |
| RAPT Therapeutics Inc | Peter Svennilson | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 30.85 per share. | 22 Sep 2020 | 608,000 | 3,835,679 (15%) | 2% | 30.9 | 18,756,800 | Common Stock |
| RAPT Therapeutics Inc | Peter Svennilson | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 22.75 per share. | 17 Aug 2020 | 538,654 | 4,443,679 (18%) | 2% | 22.8 | 12,254,379 | Common Stock |
| RAPT Therapeutics Inc | Peter Svennilson | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 22,500 | 22,500 | - | - | Stock Option (right to buy) | |
| Revolution Medicines Inc | Peter Svennilson | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2020 | 25,318 | 25,318 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Peter Svennilson | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2020 | 7,234 | 7,234 (0%) | 0% | 0 | Common Stock | |
| ORIC Pharmaceuticals Inc | Peter Svennilson | Director, Ten Percent Owner | 28 Apr 2020 | 3,500,000 | 3,575,000 | - | - | Common Stock | ||
| ORIC Pharmaceuticals Inc | Peter Svennilson | Director, Ten Percent Owner | 28 Apr 2020 | 3,500,000 | 0 | - | - | Series A Preferred Stock | ||
| ORIC Pharmaceuticals Inc | Peter Svennilson | Director, Ten Percent Owner | 28 Apr 2020 | 625,000 | 4,200,000 | - | - | Common Stock | ||
| ORIC Pharmaceuticals Inc | Peter Svennilson | Director, Ten Percent Owner | 28 Apr 2020 | 625,000 | 0 | - | - | Series B Preferred Stock | ||
| ORIC Pharmaceuticals Inc | Peter Svennilson | Director, Ten Percent Owner | 28 Apr 2020 | 416,666 | 4,616,666 | - | - | Common Stock | ||
| ORIC Pharmaceuticals Inc | Peter Svennilson | Director, Ten Percent Owner | 28 Apr 2020 | 416,666 | 0 | - | - | Series C Preferred Stock | ||
| ORIC Pharmaceuticals Inc | Peter Svennilson | Director, Ten Percent Owner | 28 Apr 2020 | 151,515 | 4,768,181 | - | - | Common Stock | ||
| ORIC Pharmaceuticals Inc | Peter Svennilson | Director, Ten Percent Owner | 28 Apr 2020 | 151,515 | 0 | - | - | Series D Preferred Stock | ||
| ORIC Pharmaceuticals Inc | Peter Svennilson | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Apr 2020 | 16,625 | 16,625 | - | - | Stock Option (right to buy) | |
| Ngm Biopharmaceuticals Inc | Peter Svennilson | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 14.95 per share. | 08 Apr 2020 | 112,602 | 17,706,978 (26%) | 0% | 15.0 | 1,683,400 | Common Stock |
| Ngm Biopharmaceuticals Inc | Peter Svennilson | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 14.38 per share. | 03 Apr 2020 | 123,728 | 17,594,376 (26%) | 0% | 14.4 | 1,779,209 | Common Stock |
| Ngm Biopharmaceuticals Inc | Peter Svennilson | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 12.41 per share. | 03 Apr 2020 | 14,587 | 17,470,648 (26%) | 0% | 12.4 | 181,025 | Common Stock |
| Ngm Biopharmaceuticals Inc | Peter Svennilson | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 12.26 per share. | 31 Mar 2020 | 118,067 | 17,441,211 (26%) | 0% | 12.3 | 1,447,501 | Common Stock |
| Ngm Biopharmaceuticals Inc | Peter Svennilson | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 12.53 per share. | 31 Mar 2020 | 118,067 | 17,323,144 (25%) | 0% | 12.5 | 1,479,380 | Common Stock |
| Ngm Biopharmaceuticals Inc | Peter Svennilson | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 12.40 per share. | 31 Mar 2020 | 14,850 | 17,456,061 (26%) | 0% | 12.4 | 184,140 | Common Stock |
| Ngm Biopharmaceuticals Inc | Peter Svennilson | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 11.63 per share. | 23 Mar 2020 | 170,387 | 17,074,284 (25%) | 0% | 11.6 | 1,981,601 | Common Stock |
| Ngm Biopharmaceuticals Inc | Peter Svennilson | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 12.22 per share. | 23 Mar 2020 | 128,377 | 17,202,661 (25%) | 0% | 12.2 | 1,568,767 | Common Stock |
| Ngm Biopharmaceuticals Inc | Peter Svennilson | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 12.49 per share. | 23 Mar 2020 | 2,416 | 17,205,077 (25%) | 0% | 12.5 | 30,176 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges